How Prescription and Over-the-Counter Drugs Affect Sexual Performance

Health, Fitness & Dieting

Wertheimer, Albert I.

Bush, Patricia J.

Raffa, Robert B.

Diseases & Physical Ailments

CRC-Press

How Prescription and Over-the-Counter Drugs Affect Sexual Performance: Their Effects on Sexual Performance

University of Minnesota College of Pharmacy, Minneapolis. Textbook for pharmacy students. DNLM: 1. Community Pharmacy Services.

Pharmacy Practice: Social and Behavioral Aspects

Politics & Social Sciences

Social Sciences

Williams Wilkins

Modern Pharmaceutical Industry: A Primer comprehensively explains the broad range of divisions in the complex pharmaceutical industry. Experts actively involved in each component discuss their own contribution to a pharmaceutical company's work and success. Divisions include regulatory affairs, research and development, intellectual property, pricing, marketing, generics, OTC, and more. The seventeen chapters included in this resource offer a wide range of topics, from discovery and formulation to post-approval and legal. Readers will be given a detailed look at the structure of a contemporary drug company and a thorough understanding of what goes on behind the scenes. Modern Pharmaceutical Industry: A Primer is a valuable resource for all pharmacy students, new hires at pharmaceutical companies, drug company management, and academic health center libraries. No other text provides a comprehensive look at one of the most dynamic industries related to the modern healthcare system.

Modern Pharmaceutical Industry: A Primer: A Primer

Medical Books

Jacobsen, Thomas M.

Administration & Medicine Economics

Jones& Bartlett Learning

Strategies in Pharmacoeconomics and Outcomes Research

Get a healthy perspective on pharmaceutical economics!Strategies in Pharmacoeconomics and Outcomes Research presents a comprehensive introduction to the economic aspects of the health sector, focusing on strategies for the development and marketing of healthcare products. A much-needed addition to this relatively new field, the book narrows health economics into the sub-discipline of pharmacoeconomics, bridging the gap between different interest groups in the pharmaceutical industry-research and development at one end, sales and marketing at the other. Using basic terminology and practical examples with descriptive tables and figures, it analyzes the implications of projecting costs of pharmaceutical products as a method of determining the viability of their development.Written from an international perspective, Strategies in Pharmacoeconomics and Outcomes Research examines the costs of drug therapy on health care systems and society through global marketing and modeling strategies, including clinical research and trial examples. Through the interlinked concepts of clinical research, outcomes research and pharmacoeconomics, the book evaluates the effectiveness of health technologies under “real world” circumstances or “normal” medical practice to achieve the optimum benefit from the resources available. The research process follows the economics of a drug?s efficacy (how it works under ideal circumstances) to its effectiveness (how it does in “real” life) to its efficiency (how cost-effective it is) in determining the baseline effects of a disease on economic and humanistic parameters.Strategies in Pharmacoeconomics and Outcomes Research also examines: 
<ul>
<li> resources and cost benefits (direct, indirect, intangible, and quality of life) </li>
<li> health economical models (decision-tree analysis, Markov-model) </li>
<li> reimbursement differences between countries due to the rate of currency exchange </li>
<li> drug monitoring and regulation . . . and includes an extensive glossary!</li>
</ul>At a time when health economics has become increasingly important, Strategies in Pharmacoeconomics and Outcomes Research is an essential tool for the pharmaceutical, diagnostic, and medical device industries to ensure the most efficient use of limited resources. The book?s practical tone and common-sense methods provide a realistic approach that will benefit pharmaceutical and medical professionals, product managers, business development managers, drug regulatory affairs officials, and clinical study coordinators in making strategic and operational decisions about pharmaceutical development, production, or consumption.

Rychlik, Reinhard

Reference

Your primary source for information on the legal issues of pharmaceutical practice, care, and activity Today’s pharmacist is faced with legal, ethical, and moral concerns in making the transition from traditional pharmacy practice to an expanded role in clinical pharmacy and patient drug management services. Pharmacy Law Desk Reference is a primer on the legal aspects of pharmaceutical practice, providing background on foundational legal concepts, and guidance on the Food, Drug, and Cosmetic Act (FDCA), the Controlled Substances Act (CSA), and the Federal Trade Commission. This unique book examines the major topics that impact pharmaceutical care, including professional liability insurance; the need for supportive personnel in pharmacy practice; patent law, trademarks, and copyrights; law and ethics; business law; HIPAA privacy in the pharmacy; electronic prescribing; and medication error reporting. Handy tables, figures, and exhibits make complex information easy to access and understand. The better pharmacists understand the regulatory and legislative framework that shapes their practice, the better they will be able to carry out their responsibilities to patients. Pharmacy Law Desk Reference offers a broad scope on established legal subjects, the current direction of the profession, and important contemporary topics that affect the clinical role of the practicing pharmacist. Each chapter is authored by a nationally recognized authority on one or more aspect of pharmacy law and many of the contributors are active in the American Society of Pharmacy Law. Topics addressed in Pharmacy Law Desk Reference include: 
<ul>
<li> telepharmacy 
</li>
<li> collaborative drug therapy management 
</li>
<li> trade secrets and trade secret protection 
</li>
<li> anti-competitive practices 
</li>
<li> the threat of civil and criminal liability 
</li>
<li> the Health Insurance Portability and Accountability Act of 1996 (HIPAA) 
</li>
<li> FDA inspections 
</li>
<li> consumer protection laws 
</li>
<li> credentialing 
</li>
<li> pharmacy compounding 
</li>
<li> accreditation 
</li>
<li> employment contracts 
</li>
<li> Medicaid and Medicare 
</li>
<li> controlled substance registration and prescription orders 
</li>
<li> forged prescription orders 
</li>
<li> and many more</li>
</ul>Pharmacy Law Desk Reference is a comprehensive resource on the professional, legal, and contemporary issues in pharmacy practice. It is a primary reference guidebook for pharmacy practitioners, leaders of state and national pharmacists associations, members of state boards of pharmacy, educators and students, and an essential addition to all pharmacy libraries.

Pharmacy Law Desk Reference

Konnor, Delbert

Routledge

International Drug Regulatory Mechanisms

Learn how international governments have committed themselves to improving access to quality health care! International Drug Regulatory Mechanisms explores the environment, organization, structure, functioning, and finance of health systems and pharmaceutical markets in 19 countries. Local experts describe each country’s experiences with and lessons learned from the regulation of pharmaceutical products. This book will help government officials, pharmacy educators, and pharmaceutical industry leaders from around the globe identify and develop successful methods for controlling pharmaceutical drug prices and utilization. In International Drug Regulatory Mechanisms, you will learn about the health care system of each country and each government’s measures to control drug costs. This text shows you what government interventions are feasible as well as effective, and the impact of these measures on consumers, government agencies, and the pharmaceutical companies and distributors. Drug policies, reimbursement concepts, and health insurance companies are all examined to give you a better working knowledge of the methodology and guidelines involving drug control in nations such as: 
<ul>
<li> Iceland </li>
<li> Canada </li>
<li> Israel </li>
<li> Malaysia </li>
<li> Argentina </li>
<li> Taiwan </li>
<li> Mexico </li>
<li> Italy </li>
</ul> International Drug Regulatory Mechanisms is an extensive text that shows how pharmaceuticals are regulated throughout the world. This book examines howdespite similar goalsprice controls, utilization controls, record keeping, and quality requirements differ greatly between countries. Using numerous graphs, tables, and figures, this one-of-a-kind resouce provides you with new insight into which strategies are superior and how to implement these strategies in your own country.

Science & Math

Chemistry

Medicine

Pharmaceutical Public Policy

As the most common health-care intervention, prescription drug use shares the most important characteristics of the health-care system in the United States. When everything works well, it makes possible breathtakingly successful applications of science to the prevention and cure of human suffering. But everything doesn’t always work well.\nPharmaceutical Public Policy provides the understanding and framework required for effective organization, financing, and delivery of pharmaceutical products and services. It supplies an overview of the policy process as well as the roles of legislation and regulation in pharmaceutical policy.\nThe book identifies the goals, objectives, and key policy issues of concern to stakeholders involved in the development of products, use of pharmaceuticals in healthcare, and administration of insurance programs by both the private and government sectors. Policy issues examined include the appropriateness of prescribing and patient adherence.\nAddressing questions of access, quality, and cost, the book considers the operation of the Affordable Care Act and Medicare Part D. It details the responsibilities of Federal providers of pharmaceutical care and private and public payers such as managed care organizations, pharmacy benefit managers, Medicare, and Medicaid.\nThe book covers the policies and practices involved in promoting pharmaceutical products. It also considers pharmacoeconomics as a response to market failure. Finally, the book describes the market, the role of the manufacturer, drug shortages, and the responsibilities of the FDA.\nThe book includes a Foreword by Jerry Avorn, MD, Professor of Medicine, Harvard Medical School; and Chief, Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Woman’s Hospital.

Business & Money

Fulda, Thomas R.

Lyles, Alan

Industries

See the best price to sell, buy, or rent books by Wertheimer, Albert I.. BookScouter helps to compare book prices from 25+ online bookstores and 30+ buyback vendors with a single search.

Books by Wertheimer, Albert I.